Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.27 Analyst target: $22.00 Upside: 166.02%
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.
See the full interactive analysis & chart →Informational only — not investment advice.